Home
>
National Drug Code (NDC)
>
acetylcysteine
acetylcysteine - 0574-0805-30 - (Acetylcysteine)
Drug Information of acetylcysteine
| Product NDC: | 0574-0805 |
| Proprietary Name: | acetylcysteine |
| Non Proprietary Name: | Acetylcysteine |
| Active Ingredient(s): | 200 mg/mL & nbsp; Acetylcysteine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of acetylcysteine
| Product NDC: | 0574-0805 |
| Labeler Name: | Paddock Laboratories, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021539 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121220 |
Package Information of acetylcysteine
| Package NDC: | 0574-0805-30 |
| Package Description: | 4 VIAL in 1 CARTON (0574-0805-30) > 30 mL in 1 VIAL |
NDC Information of acetylcysteine
| NDC Code | 0574-0805-30 |
| Proprietary Name | acetylcysteine |
| Package Description | 4 VIAL in 1 CARTON (0574-0805-30) > 30 mL in 1 VIAL |
| Product NDC | 0574-0805 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Acetylcysteine |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20121220 |
| Marketing Category Name | NDA |
| Labeler Name | Paddock Laboratories, LLC |
| Substance Name | ACETYLCYSTEINE |
| Strength Number | 200 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Antidote [EPC],Antidote for Acetaminophen Overdose [EPC],Decreased Respiratory Secretion Viscosity [PE],Increased Glutathione Concentration [PE],Mucolytic [EPC],Reduction Activity [MoA] |
